Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Lijuan Hu, Qi Wang, PhD, Xiaohui Zhang, Lan-Ping Xu, MD, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Kaiyan Liu, MD PhD, Hui Wang, PhD, Xiaojun Huang, MD, Xiao-Dong Mo

Blood (2018) 132 (Supplement 1): 5757.

https://doi.org/10.1182/blood-2018-99-109858

Published: 2018

Journal Articles

Occurrence and Severity of DLI Associated Chronic Gvhd Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Wenjing Yu, MD, Xiao-Dong Mo, Xiaohui Zhang, MD, Lan-Ping Xu, MD, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kaiyan Liu, MD PhD, Xiaojun Huang

Blood (2018) 132 (Supplement 1): 3412.

https://doi.org/10.1182/blood-2018-99-110670

Published: 2018

Journal Articles

KIT Mutation Versus MRD, Which Is More Important To Predict Relapse Of Acute Myeloid Leukemia With t (8; 21)?

Hong-Hu Zhu, MD, Daihong Liu, Hao Jiang, Ya-Zhen Qin, MS, Lan-Ping Xu, MD, Qian Jiang, Xiao-Hui Zhang, M.D., Ph.D., Huan Chen, Jin Lu, MD, Yu Wang, Li-Ru Wang, MD, Jun-Yue Chai, MM, Kai-Yan Liu, MD, Bin Jiang, MD, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 1309.

https://doi.org/10.1182/blood.V122.21.1309.1309

Published: 2013

Journal Articles

Low WT1 Expression At Diagnosis Is a Strong Predictor On Poor Outcome In Patients With t(8;21) Acute Myeloid Leukemia

Ya-Zhen Qin, MS, Hong-Hu Zhu, MD, Qian Jiang, Dai-Hong Liu, MD, PhD, Hao Jiang, Lan-Ping Xu, MD, Huan Chen, Yu Wang, MD, Xiao-hui Zhang, MD, PhD, Jun-Yue Chai MM, Li-Ru Wang, MD, Yan-Rong Liu, MS, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 1346.

https://doi.org/10.1182/blood.V122.21.1346.1346

Published: 2013

Journal Articles

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

Xiao-hui Zhang, MD, PhD, Guo-xiang Wang, MD, Yan-rong Liu, MD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Wei Han, MD, Yu Wang, MD, Hai-xia Fu, MD, Meng Lv, MD, Min Wang, MD, Yi Zhou, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 3077.

https://doi.org/10.1182/blood.V120.21.3077.3077

Published: 2012

Journal Articles

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Yuan Kong, MD, PhD, Yanrong Liu, MD, Honghu Zhu, PhD, Qian Jiang, MD, Hao Jiang, MD, Lan-Ping Xu, MD, Dai-Hong Liu, MD, PhD, Guo-Rui Ruan, PhD, Bin Jiang, MD, Kaiyan Liu, MD, Xiao-jun Huang, MD, PhD

Blood (2012) 120 (21): 1397.

https://doi.org/10.1182/blood.V120.21.1397.1397

Published: 2012

Journal Articles

Characterization of TPO Kinetics within 60 Days of Allogeneic Hematopoietic Stem Cell Transplantation and Its Correlation with Megakaryocyte Ploidy Distribution

Xiao-hui Zhang, MD, PhD, Hai-xia Fu, MD, Dai-Hong Liu, MD, PhD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 4463.

https://doi.org/10.1182/blood.V120.21.4463.4463

Published: 2012

Journal Articles

All-Trance Retinoid Acid (ATRA) Makes Refractory Immune Thrombocytopenia (RITP) Less Refractory: A Retrospective Study of Ritp Patients Treated with Combination Therapies Including ATRA

Min Wang, MD, Xiao-hui Zhang, MD, PhD, Wei Han, MD, Yu Wang, MD, Dai-Hong Liu, MD, PhD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Hai-xia Fu, MD, Meng Lv, MD, Yi Zhou, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 3338.

https://doi.org/10.1182/blood.V120.21.3338.3338

Published: 2012

Journal Articles

The PRAME and WT1 Transcripts Constitute a Good Molecular Marker Combination for Monitoring Minimal Residual Disease in Myelodysplastic Syndromes

Yazhen Qin, Honghu Zhu, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Hong-Xia Shi, Yue-yun Lai, Lan-Ping Xu, MD, Daihong Liu, Xiaojun Huang

Blood (2012) 120 (21): 3853.

https://doi.org/10.1182/blood.V120.21.3853.3853

Published: 2012

Journal Articles

Deleterious Roles of the KIR Ligand Mismatch on Acute Graft Versus Host Disease in Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation.

Xiao Jun Huang, MD, Xiang Yu Zhao, PhD., Dai Hong Liu, MD., Kai Yan Liu, PhD., Lan Ping Xu, MD., Yu Hong Chen, MD., Wei Han, MD.

Blood (2006) 108 (11): 2874.

https://doi.org/10.1182/blood.V108.11.2874.2874

Published: 2006

Journal Articles

Transplantation of HLA-Mismatched Stem Cell Transplantation without T Cell Depletion for the Treatment of Malignant Hematological Disease.

Xiao jun Huang, MD, PhD, Daihong Liu, MDPh.D, Kai Yan Liu, MDPh.D, Lan ping Xu, MD, Huan Chen, MD, Wei Han, MD, Yu Hong Chen, MD, Jing zhi Wang, MD, Zhi yong Gao, MD, Yao Chen Zhang, MD, Qian Jiang, MD, Hong xia Shi, MD, Dao pei Lu, MD

Blood (2005) 106 (11): 2915.

https://doi.org/10.1182/blood.V106.11.2915.2915

Published: 2005

NARROW

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Occurrence and Severity of DLI Associated Chronic Gvhd Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

KIT Mutation Versus MRD, Which Is More Important To Predict Relapse Of Acute Myeloid Leukemia With t (8; 21)?

Low WT1 Expression At Diagnosis Is a Strong Predictor On Poor Outcome In Patients With t(8;21) Acute Myeloid Leukemia

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Characterization of TPO Kinetics within 60 Days of Allogeneic Hematopoietic Stem Cell Transplantation and Its Correlation with Megakaryocyte Ploidy Distribution

All-Trance Retinoid Acid (ATRA) Makes Refractory Immune Thrombocytopenia (RITP) Less Refractory: A Retrospective Study of Ritp Patients Treated with Combination Therapies Including ATRA

The PRAME and WT1 Transcripts Constitute a Good Molecular Marker Combination for Monitoring Minimal Residual Disease in Myelodysplastic Syndromes

Deleterious Roles of the KIR Ligand Mismatch on Acute Graft Versus Host Disease in Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation.

Transplantation of HLA-Mismatched Stem Cell Transplantation without T Cell Depletion for the Treatment of Malignant Hematological Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only